Use of Telemonitoring to Facilitate Heart Failure Medication Titration

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 108 participants.

Also called NCT04205513

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 108 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04205513
Other papers using this trial's data
  • Carbon and Travel Cost Reduction From Remote Medication Titration for Advanced Heart Failure: A Secondary Analysis of a Randomized Controlled Trial The Canadian journal of cardiology, 2025-12 DOI, PubMed 40744126
  • The Effect of Using a Remote Patient Management Platform in Optimizing Guideline-Directed Medical Therapy in Heart Failure Patients: A Randomized Controlled Trial JACC. Heart failure, 2024-04 DOI, PubMed 38569821

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04205513. Randomized; no masking; primary purpose treatment. Start 2019-01-01 (actual); primary completion 2022-12-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Use of Telemonitoring to Facilitate Heart Failure Medication Titration
Acronym
Medly Titrate
Condition
Heart Failure
Intervention (Device)
Medly
Lead sponsor
University Health Network, Toronto (class: other)

Record details

Record id
cardio:ct-nct04205513
Content hash
81d26c6e2fb3c5e24e594cb2f90f08ad9c86fe5c10d17eaaa12e79b6581111fb